share_log

Benchmark Initiates Coverage On Heart Test Laboratories with Speculative Buy Rating, Announces Price Target of $8

Benchmark Initiates Coverage On Heart Test Laboratories with Speculative Buy Rating, Announces Price Target of $8

Benchmark 以投机性买入评级启动对心脏测试实验室的报道,宣布目标股价为8美元
Benzinga Real-time News ·  2022/08/08 09:44

Benchmark analyst Bruce Jackson initiates coverage on Heart Test Laboratories (NASDAQ:HSCS) with a Speculative Buy rating and announces Price Target of $8.

基准分析师布鲁斯·杰克逊以投机性买入评级开始对心脏测试实验室(纳斯达克股票代码:HSCS)进行报道,并宣布目标股价为8美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发